Morgan, Todd M.

Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials

Esteva, A., Feng, J., van der Wal, D., Huang, S.-C., Simko, J. P., DeVries, S., Chen, E., Schaeffer, E. M., Morgan, T. M., Sun, Y., et al. (2022) · npj Digital Medicine

Radiomics and Machine Learning in Medical ImagingAI in cancer detection

Cited by 217

Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology

Spratt, D. E., Srinivas, S., Adra, N., Ahmed, B., An, Y., Bitting, R., Chapin, B., Cheng, H. H., Cho, S. Y., D’Amico, A. V., et al. (2025) · Journal of the National Comprehensive Cancer Network

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment

Cited by 146

External validation of a digital pathology-based multimodal artificial intelligence architecture in the NRG/RTOG 9902 phase 3 trial

Ross, A. E., Zhang, J., Huang, H.-C., Yamashita, R., Keim-Malpass, J., Simko, J. P., DeVries, S., Morgan, T. M., Souhami, L., Dobelbower, M. C., et al. (2024) · European Urology Oncology

AI in cancer detectionRadiomics and Machine Learning in Medical Imaging

Cited by 35